Hutchison China Meditech Ltd (HCM)

 

HCM Share PerformanceMore

52 week high4,100.00 08/08/17
52 week low1,785.00 05/10/16
52 week change 1,857.50 (101.92%)
4 week volume181,890 25/08/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director's Share Dealing

RNS Number: 4283P Hutchison China Meditech Limited 31 August 2017 Director's Share Dealing London: Thursday, August 31, 2017: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notifications that Mr Simon To, Executive Director and Chairman, through Dynamic Drive Limited, a person closely associated with Mr To, purchased...

Chi-Med starts clinical trial of Inhibitor in lymphoma patients

Hutchison China MediTech has initiated a phase I clinical trial of HMPL689 in China.

Start of HMPL 689 Phase I Trial in China

RNS Number: 1286P Hutchison China Meditech Limited 29 August 2017 ChiMed Initiates a Phase I Clinical Trial of Selective PI3K Inhibitor HMPL689 in Lymphoma Patients in China London: Tuesday , August 29 , 2017: Hutchison China MediTech Limited ("ChiMed") (AIM/Nasdaq: HCM) has initiated a Phase I clinical trial of HMPL689 in China. HMPL-689 is a nove...

Director's Share Dealing

RNS Number: 6335O Hutchison China Meditech Limited 22 August 2017 Director's Share Dealing London: Tuesday, August 22, 2017: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notifications that Ms Edith Shih, Non-executive Director and Company Secretary, purchased a total of 4,000 American Depositary Shares of the Compa...

Directors' Share Dealing

RNS Number: 4126O Hutchison China Meditech Limited 18 August 2017 Directors' Share Dealing London: Friday, August 18, 2017: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notifications that:- (a) Mr Simon To, Executive Director and Chairman, through Wencheng Capital Limited ("WCL"), a person closely associated ("PCA") ...

Directors' Share Dealing

RNS Number: 0249O Hutchison China Meditech Limited 15 August 2017 Directors' Share Dealing London: Tuesday, August 15 , 2017: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notifications that:- (a) Mr Simon To, Executive Director and Chairman, through Dynamic Drive Limited, a person closely associated ("PCA") with Mr T...

Director's Share Dealing

RNS Number: 6331N Hutchison China Meditech Limited 10 August 2017 Director's Share Dealing London: Thursday, August 10 , 2017: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notifications that Ms Edith Shih, Non-executive Director and Company Secretary, purchased a total of 1,807 American Depositary Shares of the Comp...

Director Deals - Hutchison China Meditech Ltd (HCM)

Paul Carter, Non Executive Director, bought 724 shares in the company on the 2nd August 2017 at a price of 3425.00p. The...

Equity Research (HCM)

edison investment research
Hutchison China MediTech Limited
13/06/2017
At ASCO, Hutchison China MediTech (HCM) presented detailed Phase III trial results for one of its leading assets, fruquintinib (third-line colorectal cancer). Full data from the China-based FRESCO...
edison investment research
Hutchison China MediTech Limited
13/06/2017
At ASCO, Hutchison China MediTech (HCM) presented detailed Phase III trial results for one of its leading assets, fruquintinib (third-line colorectal cancer). Full data from the China-based FRESCO...
edison investment research
Hutchison China MediTech Limited
11/05/2017
Despite a strong run over the last 12 months, our increased valuation of $2.7bn suggests the market overlooks HCM’s full R&D potential. Multiple catalysts are on the horizon in 2017/18; notably...

Latest discussion posts More

  • Two very big trades

    Wondering whether the two big trades went through this afternoon we're buys. Total of 43000 shares were traded at #36.75. Is it show of continued directors' confidence?
    15-Sep-2017
    sporty investor
  • Director Buys

    More Director buys announded today - these guys know exactly where the Company is headed over the next few years and how today's mcap will pale into insignificance in a few ...
    31-Aug-2017
    David Global
  • Re: DCF Forecast

    Hmmm Given they reckon we're currently overvalued by more than 20% I'm hoping that research isn't too well informed. BB
    24-Aug-2017
    Boring Bernie

Users' HoldingsMore

Users who hold Hutchison China Meditech Ltd also hold..
RDS 'B'24%
GLAXOSMITHKLINE21%
LLOYDS GRP.20%
NATIONAL GRID19%
BP17%

Codes & Symbols

ISINKYG4672N1016
SymbolsHCM, LSE:HCM, HCM.L, HCM:LN, LON:HCM, XLON:HCM